期刊文献+

胰岛细胞抗体阳性的成人隐匿性自身免疫糖尿病患者的胰岛β细胞功能 被引量:8

Islet β cell function in latent autoimmune diabetes in adults with islet cell antibodies
下载PDF
导出
摘要 目的 :探讨胰岛细胞抗体 (ICA)和谷氨酸脱羧酶抗体 (GAD Ab)对成人隐匿性自身免疫糖尿病 (LADA)患者胰岛功能的影响和预测价值。方法 :对单独ICA阳性的LADA14例 ,单独GAD Ab阳性的LADA 10例 ,GAD Ab和ICA同时阳性的LADA 7例 ,两抗体均阴性的 2型糖尿病 (T2DM) 2 5例 ,每半年随访一次 (第 2年除外 )直至第 5年 ,测定患者空腹C肽 (FCP)和 10 0g馒头餐后 2hC肽 (2°CP)及糖代谢指标。采用放射免疫法测定GAD Ab和C肽 ,酶联免疫吸附法 (ELISA)测定ICA。结果 :单独GAD Ab阳性和两抗体均阳性组的FCP从随访第 2 .5年开始下降 ,FCP较入组时下降≥ 5 0 %的患者百分比分别从第 3年和第 3.5年升至 6 0 %和 71.4 % ,单独ICA阳性组和抗体阴性的T2DM组则无显著性变化。单独GAD Ab阳性组中 4 / 10例、两抗体均阳性组 1/ 10例出现胰岛功能衰竭 ,前者与单独ICA阳性组 (0 / 14例 )和两抗体均阴性组 (0 / 2 5例 )比较有统计学意义 (均P <0 .0 5 )。ICA与FCP间无显著性相关 (rs= 0 .2 5 8,P <0 .0 5 ) ,多元回归分析显示GAD Ab对FCP的影响远大于ICA。结论 :GAD Ab阳性的LADA患者胰岛 β细胞功能较ICA阳性的LADA以及T2DM下降更快 ,GAD Ab滴度是预测胰岛功能减退速度的重要因素 。 Objective To explore the predictive value and influence of islet cell antibody (ICA) and glutamic acid decarboxylase antibody (GAD-Ab) for β cell function in latent autoimmune diabetes in adults(LADA) patients.Methods Fifty-six patients with initially diagnosed type 2 diabetes (including 10 cases of GAD-Ab-positive alone, 14 ICA-positive alone, 7 GAD-Ab and ICA-positive and 25 GAD-Ab and ICA negative) were followed up every 6 months (except the 2nd year) until the 5th year. Their fasting and postprandial C-peptide and glycemic control were measured. GAD-Ab was determined by radioimmunoprecipitation assay and ICA by ELISA kit. Results Decreased fasting C-peptide was found in patients with GAD-Ab alone and patients with GAD-Ab and ICA in the 2.5th year and to the end of the follow-up. The percentage of patients whose C-peptide decreased 50% or more compared with the baseline in the above 2 groups reached 60.0% in the 3nd year and 71.4% in the 3.5th year,respectively. No changes of the above parameters were found in ICA-positive alone group and GAD-Ab and ICA negative group. Complete β-cell failure was found in 4 of the 10 patients in GAD-Ab alone group and in 1 of the 10 patients in ICA and GAD-Ab positive group. The number of failure patients in GAD-Ab alone group was more than that of the other 2 groups (P<0.05 in both groups). There was no significant correlation between ICA index and FCP. Multiple stepwise regression analysis demonstrated that GAD-Ab contributed much more to FCP than ICA did.Conclusion The islet β cell function decreases more quickly in GAD-Ab positive LADA patients than in ICA positive ones. The titer of GAD-Ab is an important prognostic factor in islet β cell function, and the presentation of ICA-positive alone can not predict β cell function in LADA patients.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2004年第3期309-314,共6页 Journal of Central South University :Medical Science
基金 国家自然科学基金 (39370 343) 卫生部优秀青年科技人才基金 (Q942 0 ) 湖南省卫生厅重点科研基金(9736 2 0 0 1 Z0 4 )
关键词 胰岛细胞 抗体 阳性 隐匿性 自身免疫 糖尿病 Β细胞功能 GAD-AB ICA latent autoimmune diabetes in adults islet β-cell function glutamic acid decarboxylase antibody islet cell antibody
  • 相关文献

参考文献20

  • 1Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease [J]. Diabetes, 1993, 42 (2): 359-362. 被引量:1
  • 2Theophanides CG, Pyke DA, Watkins PJ. Islet function in diabetics with persistent islet cell antibodies [J]. Diabetes, 1978, 27 (suppl 1): 265-266. 被引量:1
  • 3Torn C, Landin-Olsson M, Lernmark A., et al. Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflect different courses of beta cell damage [J]. Autoimmunity, 2001, 33 (2):115-120. 被引量:1
  • 4Nakanishi K, Kobayashi T, Miyashita H, et al. Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes of long duration: use of a sensitive C-peptide radioimmunoassay [J]. Meta 被引量:1
  • 5Wagner R, Genorese S, Bosi E, et al. Slow metabolic deterioration towards diabetes in ICA positive patients with autoimmune polyendocrine disease [J]. Diabetologia, 1994, 37 (4): 365-371. 被引量:1
  • 6Kohnert KD, Besch W, Rjasanowski I. Discordant results in the assay of cytoplasmic islet cell autoantibodies with ELISA and immunohistochemical techniques [J]. Eur J Clin Chem Clin Biochem, 1995, 33 (7): 447-449. 被引量:1
  • 7Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity [J]. Diabetologia, 1995, 38 (7): 816-822. 被引量:1
  • 8Schmidli RS, Colman PC, Bonifacio E. participating laboratories: Disease sensitivity and specificity of fifty-two assays for glutamic acid decarboxylase antibodies: the Second International GAD-Ab Workshop [J]. Diabetes, 1995, 44 (6): 636-640. 被引量:1
  • 9Gottsater A, Lernmark A., Landin-Olsson M, et al.β-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type Ⅱ diabetic patients [J]. Diabetes Care, 1993, 16 (6): 902-909. 被引量:1
  • 10Turner R, Stratton I, Horton V, et al. UKPDS25: autoantibodies to ICA and GAD for prediction of insulin requirement in type 2 diabetes [J]. Lancet, 1997, 350 (9087): 1288-1293. 被引量:1

二级参考文献20

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2[1]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000,85:76-80. 被引量:1
  • 3[2]Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol, 2001, 169:453-459. 被引量:1
  • 4[4]Johansson BL, Brog K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17:181-189. 被引量:1
  • 5[5]Di Mario U, Dotta F. Modulation of antigen expression in relation to intervention strategies in type 1 diabetes. Diabete Metab Rev, 1993.245-249. 被引量:1
  • 6[6]Kobayashi T, Nakanishi K, Murase T , et al. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes, 1996,45:622-626. 被引量:1
  • 7[7]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve β cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130. 被引量:1
  • 8[8]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev,2002,18:114-117. 被引量:1
  • 9Tuomi T,Groop LC,Zimmet PZ,et a1.Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non—insulin—dependent onset of disease.Diabetes,1993,42:359—362. 被引量:1
  • 10The Expert Committee of the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997,20: 1183-1197. 被引量:1

共引文献164

同被引文献96

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部